SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-071734
Filing Date
2024-06-14
Accepted
2024-06-14 16:00:13
Documents
14
Period of Report
2024-06-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417305d1_8k.htm   iXBRL 8-K 46763
2 EXHIBIT 99.1 tm2417305d1_ex99-1.htm EX-99.1 102025
  Complete submission text file 0001104659-24-071734.txt   347183

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bpmc-20240612.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpmc-20240612_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpmc-20240612_pre.xml EX-101.PRE 22379
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2417305d1_8k_htm.xml XML 3569
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 241044577
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)